J
John G.F. Cleland
Researcher at National Institutes of Health
Publications - 1276
Citations - 125527
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Papers
More filters
Journal ArticleDOI
Optimizing clinical use of biomarkers in high-risk acute heart failure patients.
Biniyam G. Demissei,Mattia A.E. Valente,John G.F. Cleland,Christopher M. O'Connor,Marco Metra,Piotr Ponikowski,John R. Teerlink,Gad Cotter,Beth A. Davison,Michael M. Givertz,Daniel M. Bloomfield,Howard C. Dittrich,Peter van der Meer,Dirk J. van Veldhuisen,Hans L. Hillege,Adriaan A. Voors +15 more
TL;DR: A multimarker, multi‐time‐point analysis of biomarkers for the prediction of post‐discharge clinical outcomes in high‐risk AHF patients is performed.
Journal ArticleDOI
Recall of lifestyle advice in patients recently hospitalised with heart failure: A EuroHeart Failure Survey analysis
Mitja Lainscak,John G.F. Cleland,Mattie J. Lenzen,Samantha Nabb,Irena Keber,Ferenc Follath,Michel Komajda,Karl Swedberg +7 more
TL;DR: There are limited data on recall and implementation of lifestyle advice in patients with heart failure (HF) and the use of these guidelines is likely to vary between patients.
Journal ArticleDOI
The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis.
Cecilia Linde,John G.F. Cleland,Michael R. Gold,J. Claude Daubert,Anthony S.L. Tang,James B. Young,Lou Sherfesee,William T. Abraham +7 more
TL;DR: To explore possible associations that may explain the greater benefit from cardiac resynchronization therapy (CRT) reported amongst women, a large number of studies have looked at the effect of age, gender, and prior history on the benefit of CRT.
Journal ArticleDOI
Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study
N G Bellenger,Kim Rajappan,Shelley L. Rahman,Avijit Lahiri,U Raval,J Webster,Gordon D Murray,Andrew J.S. Coats,John G.F. Cleland,Dudley J. Pennell +9 more
TL;DR: Treatment of chronic stable heart failure with carveilol results in significant improvement in left ventricular volumes and function, which might contribute to the benefits of carvedilol on mortality and morbidity in patients with chronic heart failure.
Journal ArticleDOI
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model
Ramin Shadman,Jeanne E. Poole,Todd F. Dardas,Dariush Mozaffarian,John G.F. Cleland,Karl Swedberg,Karl Swedberg,Aldo P. Maggioni,Inder S. Anand,Peter E. Carson,Alan B. Miller,Wayne C. Levy +11 more
TL;DR: Several easily obtained baseline demographic and clinical variables, beyond ejection fraction and New York Heart Association functional class, are independently associated with a disproportionately increased risk of sudden death.